Involvement of P13-K in neuroprotective effects of the 1,25-dihydroxyvitamin D3 analogue - PRI-2191

Pharmacological Reports

Volumn 58, Issue 6, 2006, Pages 900-907

  Regulska, Magdalena ^a   Leśkiewicz, Monika ^a   Budziszewska, Bogusława ^a   Kutner, Andrzej ^b   Basta Kaim, Agnieszka ^a   Kubera, Marta ^a   Jaworska Feil, Lucylla ^a   Lasoń, Władysław ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b INDUSTRIAL CHEMISTRY RESEARCH INSTITUTE   (Poland)

Author keywords

1,25 dihydroxyvitamin D3; Hydrogen peroxide; Neurotoxicity; PRI 1890 and PRI 1901; PRI 2191; Protein kinases; SH SY5Y cells

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CALCITRIOL; CALCITRIOL DERIVATIVE; HYDROGEN PEROXIDE; LACTATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PRI 1890; PRI 1901; PRI 2191; SECOSTEROID; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; TACALCITOL; UNCLASSIFIED DRUG; WORTMANNIN; 1 ALPHA,24 DIHYDROXYVITAMIN D3; 1 ALPHA,24-DIHYDROXYVITAMIN D3; ANDROSTANE DERIVATIVE; DIHYDROXYCOLECALCIFEROL; DRUG DERIVATIVE; NEUROPROTECTIVE AGENT;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; HUMAN; HUMAN CELL; INCUBATION TIME; NERVE CELL DEGENERATION; NERVE DEGENERATION; NEUROBLASTOMA CELL; NEUROPROTECTION; TUMOR CELL LINE; PHYSIOLOGY; SECRETION; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; CALCITRIOL; CELL LINE, TUMOR; DIHYDROXYCHOLECALCIFEROLS; HUMANS; HYDROGEN PEROXIDE; L-LACTATE DEHYDROGENASE; MAP KINASE SIGNALING SYSTEM; NEUROPROTECTIVE AGENTS;

EID: 33846311771     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Aikawa R, Komuro I, Yamazaki T, Zou Y, Kudoh S, Tanaka M, Shiojima I et al.: Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats. J Clin Incest, 1997, 100, 1813-1821.
2. Bhat NR, Zhang P: Hydrogen peroxide activation of multiple mitogen-activated protein kinases in an oligodendrocyte cell line: role of extracellular signal-regulated kinase in hydrogen peroxide-induced cell death. J Neurochem, 1999, 72, 112-119.
3. Bonni A, Brunet A, West AE, Datta SR, Takasu MA, Greenberg ME: Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science, 1999, 286, 1358-1362.
4. Brewer LD, Thibault V, Chen K-C, Langub MC, Land-field PW, Porter NM: Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons. J Neurosci, 2001, 21, 98-108.
5. Brunet A, Datta SR, Greenberg ME: Transcription-dependent and -independent control of neuronal survival by the P13K-Akt signaling pathway. Curr Opin Neurobiol, 2001, 11, 297-305.
6. Cantoni O, Boscoboinik D, Fiorani M, Stauble B, Azzi A: The phosphorylation state of MAP-kinases modulates the cytotoxic response of smooth muscle cells to hydrogen peroxide. FEBS Lett, 1996, 389, 285-288.
7. Chalecka-Franaszek E, Chuang DM: Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons. Proc Natl Acad Sci USA, 1999, 96, 8745-8750.
8. Chen KB, Lin AM, Chiu TH: Systemic vitamin D3 attenuated oxidative injuries in the locus coeruleus of rat brain. Ann NY Acad Sci, 2003, 993, 313-324.
9. Coffer PJ, Jin J, Woodgett JR: Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem J, 1998, 335 (Pt 1), 1-13.
10. Crossthwaite AJ, Hasan S, Williams RJ: Hydrogen peroxide-mediated phosphorylation of ERK1/2, Akt/PKB and JNK in cortical neurones: dependence on Ca(2+) and P13-kinase. J Neurochem, 2002, 80, 24-35.
11. De Sarno P, Li X, Jope RS: Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium. Neuropharmacology, 2002, 43, 1158-1164.
12. Denu JM, Tanner KG: Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation. Biochemistry, 1998, 37, 5633-5642.
13. Dohi T, Yasugi E, Oshima M: Activation of mitogen activated protein kinase in dolichyl phosphate-induced apoptosis in U937 cells. Biochem Biophys Res Commun, 1996, 224, 87-91.
14. 3 inhibits the expression of inducible nitric oxide synthase in rat central nervous system during experimental allergic encephalomyelitis. Mol Br Res, 1997, 45, 255-267.
15. Garcioni E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D: New clues about vitamin D functions in the nervous system. Trends Endo Metab, 2002, 13, 100-105.
16. Guyton KZ, Liu Y, Gorospe M, Xu Q, Holbrook NJ: Activation of mitogen-activated protein kinase by H2O2. Role in cell survival following oxidant injury. J Biol Chem, 1996, 271, 4138-4142.
17. Harper SJ, LoGrasso P: Signalling for survival and death in neurones: the role of stress-activated kinases, JNK and p38. Cell Signal, 2001, 13, 299-310.
18. 3 against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture. Neuropharmacology, 2001, 40, 761-771.
19. Jimenez LA, Zanella C, Fung H, Janssen YM, Vacek P, Charland C, Goldberg J, Mossman BT: Role of extracellular signal-regulated protein kinases in apoptosis by asbestos and H2O2. Am J Physiol, 1997, 273, L1029-L1035.
20. Kihara T, Shimohama S, Sawada H, Honda K, Nakamizo T, Kanki R, Yamashita H, Akaike A: Protective effect of dopamine D2 agonists in cortical neurons via the phosphatidylinositol 3 kinase cascade. J Neurosci Res, 2002, 70, 274-282.
21. Landfield PW, Cadwallader-Neal L: Long-term treatment with calcitriol. (1,25(OH)2 vitD3) retards a biomarker of hippocampal aging in rats. Neurobiol Aging, 1998, 19, 469-477.
22. Lin AM, Chen KB, Chao PL: Antioxidative effect of vitamin D3 on zinc-induced oxidative stress in CNS. Ann NY Acad Sci, 2005, 1053, 319-329.
23. Lin AM, Fan SF, Yang DM, Hsu LL, Yang CH: Zinc-induced apoptosis in substantia nigra of rat brain: neuroprotection by vitamin D3. Free Radic Biol Med, 2003, 34, 1416-1425.
24. Marcinkowska E, Kutner A: Side-chain modified vitamin D analogs require activation of both PI 3-K and erk1,2 signal transduction pathways to induce differentiation of human promyelocytic leukemia cells. Acta Biochim Pol, 2002, 49, 393-406.
25. Molina-Holgado F, Pinteaux E, Heenan L, Moore JD, Rothwell NJ, Gibson RM: Neuroprotective effects of the synthetic cannabinoid HU-210 in primary cortical neurons are mediated by phosphatidylinositol 3-kinase/ AKT signaling. Mol Cell Neurosci, 2005, 28, 189-194.
26. Moore ME, Piazza A, McCartney Y, Lynch MA: Evidence that vitamin D3 reverses age-related inflammatory changes in the rat hippocampus. Biochem Soc Trans, 2005, 33, 573-577.
27. 3 analogs. Endocrinology, 1997, 138, 12-18.
28. Neveu I, Naveilhan P, Jehan F, Baudet C, Wion D, De Luca HF, Brachet P: 1,25-dihydroxyvitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells. Brain Res Mol Brain Res, 1994, 24, 70-76.
29. Otani N, Nawashiro H, Fukui S, Nomura N, Yano A, Miyazawa T, Shima K: Differential activation of mitogen-activated protein kinase pathways after traumatic brain injury in the rat hippocampus. J Cereb Blood Flow Metab, 2002, 22, 327-334.
30. Ravid A, Rubinstein E, Gamady A, Rotem C, Liberman UA, Koren R: Vitamin D inhibits the activation of stress-activated protein kinases by physiological and environmental stresses in keratinocytes. J Endocrinol, 2002, 173, 525-532.
31. Shinpo K, Kikuchi S, Sasaki H, Moriwaka F, Tashiro K: Effect of 1,25-dihydroksyvitamin D3 on cultured mesencephalic dopaminergic neurons to the combined toxicity caused by L-buthione sulfoximine and 1-methyl-4-phenylpyridine. J Neurosci Res, 2000, 62, 374-382.
32. Tetich M, Dziedzicka-Wasylewska M, Kuśmider M, Kutner A, Leśkiewicz M, Jaworska-Feil L, Budziszewska B et al.: Effects of PRI-2191 a low-calcemic analog of 1,25-dihydroxyvitamin D3 on the seizure-induced changes in brain gene expression and immune system activity in the rat. Brain Res, 2005, 1039, 1-13.
33. Tetich M, Kutner A, Leśkiewicz M, Budziszewska B, Lasoń W: Neuroprotective effects of (24R)-1,24-dihydroxycholecalciferol in human neuroblastoma SH-SY5Y cell line. J Steroid Biochem Mol Biol, 2004, 89-90, 365-370.
34. Wang JY, Wu JN, Cherng TL, Hoffer BJ, Chen HH, Borlongan CV, Wang Y: Vitamin D3 attenuates 6-hydroxydopamine-induced neurotoxicity in rats. Brain Res, 2001, 904, 67-75.
35. Wang W, Gao C, Hou XY, Liu Y, Zong YY, Zhang GY: Activation and involvement of JNK1/2 in hydrogen peroxide-induced neurotoxicity in cultured rat cortical neurons. Acta Pharmacol Sin, 2004, 25, 630-666.
36. Wang W, Hou XY, Gao C, Liu Y, Zong YY, Zhang GY: Regulation of c-Jun N-terminal kinase activation in hydrogen peroxide induced neurotoxicity. J Neurocytol, 2003, 32, 143-151.
37. 3 attenuates cortical infarction induced by middle cerebral arterial ligation in rats. Neuropharmacology, 2000, 39, 873-880.
38. Wojtal K, Trojnar MK, Czuczwar SJ: Endogenous neuroprotective factors: neurosteroids. Pharmacol Rep, 2006, 58, 335-340.
39. Yu X, Rajala RV, McGinnis JF, Li F, Anderson RE, Yan X, Li S, Elias RV et al.: Involvement of insulin/phosphoinositide 3-kinase/Akt signal pathway in 17 beta-estradiol-mediated neuroprotection. J Biol Chem, 2004, 279, 13086-13094.
40. Zhang Y, Zhang J, Studzinski GP: AKT pathway is activated by 1,25-hydroxyvitamin D3 and participates in its anti-apoptotic effect and cell cycle control in differentiating HL60 cells. Cell Cycle, 2006, 5, 447-451.
41. Zhang L, Zhou R, Xiang G: Stepholidine protects against H2O2 neurotoxicity in rat cortical neurons by activation of Akt. Neurosci Lett, 2005, 383, 328-332.
42. Zhou Y, Wang Q, Evers BM, Chung DH: Signal transduction pathways involved in oxidative stress-induced intestinal epithelial cell apoptosis. Pediatr Res, 2005, 58, 1192-1197.